Prognosis after resection or ablation of hepatocellular carcinoma: real-world evidence from a Danish population-based cohort
This population-based real-world study demonstrated that current curative-intent treatment strategies for early HCC are insufficient for long-term disease control, and that we need more effective management and follow-up of patients with HCC.
Authors
- Britta Weber (ORCID: https://orcid.org/0000-0002-7099-1204)
- Nikolaj Skou (ORCID: https://orcid.org/0000-0003-1103-556X)
- Simona Conte (ORCID: https://orcid.org/0009-0007-6992-1114)
- Andreas Halgreen Eiset (ORCID: https://orcid.org/0000-0002-5487-8359)
- Anders Riegels Knudsen (ORCID: https://orcid.org/0000-0002-5630-8317)
- Peter Jepsen
- Clara Stenderup
- Gerda Elisabeth Villadsen
Institutions
- Aarhus University Hospital (DK)
- Regional Hospital Horsens (DK)
- AstraZeneca (Singapore) (SG)
- AstraZeneca (Switzerland) (CH)
Publication Details
- Journal
- Scandinavian Journal of Gastroenterology
- Published
- 2025-12-23
- DOI
- https://doi.org/10.1080/00365521.2025.2604781
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00